BRKR

Bruker CorporationNASDAQHealthcare

$36.76+1.88%ClosedMarket Cap: $5.60B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-30	Guggenheim	—	Buy	—
2026-02-13	TD Cowen	—	Hold	—
2026-02-13	Goldman Sachs	—	Sell	—
2026-02-13	Barclays	—	Overweight	—
2026-02-13	Citigroup	—	Neutral	—
2026-01-26	Guggenheim	—	Buy	—
2026-01-07	TD Cowen	—	Hold	—
2025-12-15	Barclays	—	Overweight	—
2025-12-15	Wells Fargo	—	Overweight	—
2025-12-15	JP Morgan	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$2.43	$3.73B	7
Sun Dec 31	$2.77	$3.92B	1
Mon Dec 31	$3.12	$4.17B	1
Tue Dec 31	$3.40	$4.24B	1

BRKR | Bruker Corporation Analyst Ratings & Price Target - InvestLog